Life Sciences
After a Significant Correction, Beam Therapeutics Looks Interesting Again
Here's what aggressive traders could do now.
Novocure Breaks a Major Support Zone: What Now?
Here's what smashing what was a zone of support means for the stock.
Why Are CRISPR Therapeutics Charts Saying 'Buy'?
Here's where traders could go long.
Intuitive Surgical's Charts Are Flashing Positive Signs Ahead of Earnings
The maker of robotic products for minimally invasive surgery looks like a long play based on its technical signals.
Regeneron Set to Reach New Heights: $1,000 in Sight?
Here's how traders can play it.
Johnson & Johnson's Rally Does Not Move the Needle
It will take more than the company's potential talc litigation settlement to reverse the stock's downward path the past 12 months.
Boston Scientific's Wicked Rally Can Take the Stock 20% Higher
BSX has rallied the past nine months.
Novavax's Charts Are in Critical Condition
Trying to catch this drug developer's stock appears risky.
It's Time to Reevaluate Moderna's Charts
Here's what I think we'll see up ahead.
Are Danaher Shares Poised for a Rally?
Keep this stock on your watch list.